Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Verschueren

Showing results (81-90 of 155) with videos related to

Pageof 16
Sort By:
Rheumatology Advances in Practice|March 24, 2026
Unmet needs in patients with RA judged in remission by the rheumatologist: a semi-structured interview studyElias De Meyst, Marine Piessens, Jeannine Engelen, et al.
Annals of the Rheumatic Diseases|April 4, 2020
Two-year cost-effectiveness of different COBRA-like intensive remission induction schemes in early rheumatoid arthritis: a piggyback study on the pragmatic randomised controlled CareRA trialSofia Pazmino, Annelies Boonen, Veerle Stouten, et al.
Annals of the Rheumatic Diseases|April 3, 2021
Five-year treat-to-target outcomes after methotrexate induction therapy with or without other csDMARDs and temporary glucocorticoids for rheumatoid arthritis in the CareRA trialVeerle Stouten, René Westhovens, Sofia Pazmino, et al.
Rheumatology (Oxford, England)|September 19, 2023
Patterns and determinants of response to novel therapies in juvenile and adult-onset polyarthritisClément Triaille, Pierre Quartier, Lien De Somer, et al.
Trials|October 15, 2024
Treat-to-target fixed dose rituximab retreatment versus fixed interval retreatment with disease activity-guided rituximab dose optimisation for patients with rheumatoid arthritis: study protocol for a multicentre randomised controlled superiority trial focusing on long-term disease impact (RITUXERA)Elias De Meyst, Delphine Bertrand, Johan Joly, et al.
Arthritis Care & Research|December 30, 2015
Unraveling Patient-Preferred Health and Treatment Outcomes in Early Rheumatoid Arthritis: A Longitudinal Qualitative StudyKristien van der Elst, Sabrina Meyfroidt, Diederik De Cock, et al.
Rheumatology Advances in Practice|January 5, 2023
Impact of COVID-19 pandemic on the management of patients with RA: a survey of rheumatologists in six European countriesPedro M Machado, Patrick Verschueren, Rebecca Grainger, et al.
Diagnostics (Basel, Switzerland)|September 28, 2023
Ultrasonographic Presentation and Anatomic Distribution of Lung Involvement in Patients with Rheumatoid ArthritisMarie Vermant, Alexandros Kalkanis, Tinne Goos, et al.
The European Journal of General Practice|December 19, 2015
A general practice perspective on early rheumatoid arthritis management: A qualitative study from FlandersSabrina Meyfroidt, Judith Stevens, Jan De Lepeleire, et al.
European Journal of Gastroenterology & Hepatology|September 8, 2016
Incidence of renal cell carcinoma in inflammatory bowel disease patients with and without anti-TNF treatmentLucas Wauters, Thomas Billiet, Konstantinos Papamichael, et al.
Pageof 16

Showing results (81-90 of 155) with videos related to

Sort By:
Pageof 16
Rheumatology Advances in Practice|March 24, 2026
Unmet needs in patients with RA judged in remission by the rheumatologist: a semi-structured interview studyElias De Meyst, Marine Piessens, Jeannine Engelen, et al.
Annals of the Rheumatic Diseases|April 4, 2020
Two-year cost-effectiveness of different COBRA-like intensive remission induction schemes in early rheumatoid arthritis: a piggyback study on the pragmatic randomised controlled CareRA trialSofia Pazmino, Annelies Boonen, Veerle Stouten, et al.
Annals of the Rheumatic Diseases|April 3, 2021
Five-year treat-to-target outcomes after methotrexate induction therapy with or without other csDMARDs and temporary glucocorticoids for rheumatoid arthritis in the CareRA trialVeerle Stouten, René Westhovens, Sofia Pazmino, et al.
Rheumatology (Oxford, England)|September 19, 2023
Patterns and determinants of response to novel therapies in juvenile and adult-onset polyarthritisClément Triaille, Pierre Quartier, Lien De Somer, et al.
Trials|October 15, 2024
Treat-to-target fixed dose rituximab retreatment versus fixed interval retreatment with disease activity-guided rituximab dose optimisation for patients with rheumatoid arthritis: study protocol for a multicentre randomised controlled superiority trial focusing on long-term disease impact (RITUXERA)Elias De Meyst, Delphine Bertrand, Johan Joly, et al.
Arthritis Care & Research|December 30, 2015
Unraveling Patient-Preferred Health and Treatment Outcomes in Early Rheumatoid Arthritis: A Longitudinal Qualitative StudyKristien van der Elst, Sabrina Meyfroidt, Diederik De Cock, et al.
Rheumatology Advances in Practice|January 5, 2023
Impact of COVID-19 pandemic on the management of patients with RA: a survey of rheumatologists in six European countriesPedro M Machado, Patrick Verschueren, Rebecca Grainger, et al.
Diagnostics (Basel, Switzerland)|September 28, 2023
Ultrasonographic Presentation and Anatomic Distribution of Lung Involvement in Patients with Rheumatoid ArthritisMarie Vermant, Alexandros Kalkanis, Tinne Goos, et al.
The European Journal of General Practice|December 19, 2015
A general practice perspective on early rheumatoid arthritis management: A qualitative study from FlandersSabrina Meyfroidt, Judith Stevens, Jan De Lepeleire, et al.
European Journal of Gastroenterology & Hepatology|September 8, 2016
Incidence of renal cell carcinoma in inflammatory bowel disease patients with and without anti-TNF treatmentLucas Wauters, Thomas Billiet, Konstantinos Papamichael, et al.
Pageof 16